In this episode of OvaryActive, the Docs dive headfirst into the hot (flash) topic of hormone replacement therapy (HRT) for breast cancer survivors. It's complicated, it's emotional, and yes, it's got a healthy splash of perimenopause thrown in—because nothing says "fun" like navigating midlife with a side of oncology. They talk all about the swirling myths, the clickbait headlines, and the TikTok "experts" who got their MDs from the comments section. Dr. Dunsmoor-Su even shares her own experience with breast cancer and menopause, adding a real-world lens to the science. We've got real talk on estrogen's role in cancer risk, the current scientific consensus on HRT post-diagnosis, and why early detection still matters. You'll walk away with a clearer sense of what's fact, what's fiction, and what to actually bring up with your doctor (hint: not what Becky from Instagram said). What you'll hear in this episode: [0:57] The "Influencer Effect" [1:18] Dr. Rebecca Dunsmoor-Su's experience with breast cancer and menopause [7:40] The Gold Standard: Mammograms [11:25] Alternative screening methods: myths and facts [16:48] Estrogen's role in breast cancer [20:43] Understanding HRT & breast cancer [30:24[ Tamoxifen & Aromatase inhibitors: a comparison [39:22] Women's health needs more research Resources: thewisdomstudy.org Follow the show @OvaryActive Instagram | YouTube Meet the Docs: More information about Dr. Rebecca Dunsmoor-Su: Gennev: www.gennev.com/clinician/dr-rebecca-dunsmoor-su LinkedIn @rebecca-dunsmoor-su More information about Dr. Amy Voedisch: Stanford Medical Clinic: stanfordhealthcare.org/doctors/v/amy-voedisch.html

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related